Efficacy and Safety of First-Line Bosutinib versus Imatinib in the BFORE trial: 18-Month Follow-up

被引:0
|
作者
Clark, R. E. [1 ]
Gambacorti-Passerini, C. [2 ]
Deininger, M. [3 ]
Mauro, M. J. [4 ]
Chuah, C. [5 ]
Kim, D. -W. [6 ]
Dyagil, I. [7 ]
Glushko, N. [8 ]
Milojkovic, D. [9 ]
Le Coutre, P. [10 ]
Garcia-Gutierrez, V. [11 ]
Crescenzo, R. [12 ]
Leip, E. [13 ]
Bardy-Bouxin, N. [14 ]
Hochhaus, A. [15 ]
Bruemmendorf, T. H. [16 ]
Cortes, J. E. [17 ]
机构
[1] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England
[2] Univ Milano Bicocca, San Gerardo Hosp, Monza, Italy
[3] Univ Utah, Salt Lake City, UT USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] Singapore Gen Hosp, Duke NUS Grad Med Sch, Singapore, Singapore
[6] Catholic Univ Korea, Seoul St Marys Hosp, Leukemia Res Inst, Seoul, South Korea
[7] Natl Res Ctr Radiat Med, Kiev, Ukraine
[8] Ivano Frankivsk Reg Clin Hosp, Ivano Frankivsk, Ukraine
[9] Imperial Coll, Hammersmith Hosp, Haematol, London, England
[10] Charite Univ Med Berlin, Berlin, Germany
[11] Hosp Univ Ramon & Cajal, IRYCIS, Madrid, Spain
[12] Pfizer Inc, Collegeville, PA USA
[13] Pfizer Inc, Cambridge, MA USA
[14] Pfizer Int Operat Oncol, Paris, France
[15] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany
[16] Univ Klinikum RWTH Aachen, Aachen, Germany
[17] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
Bosutinib; Chronic myeloid leukaemia; Clinical trial;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH18-OR-0
引用
收藏
页码:7 / 8
页数:2
相关论文
共 50 条
  • [41] Prevention of occlusal caries using Vanish™ XT: an 18-month follow-up randomized clinical trial
    Baik, Alaa
    Alamoudi, Najlaa
    Felemban, Osama
    El-Housseiny, Azza
    Almabadi, Eman
    Baik, Khadijah
    Altuwirqi, Amani
    Masoud, Ibrahim
    BMC ORAL HEALTH, 2024, 24 (01):
  • [42] Sodium Hypochlorite Versus Formocresol and Ferric Sulfate Pulpotomies in Primary Molars: 18-month Follow-up
    Farsi, Deema J.
    El-Khodary, Heba M.
    Farsi, Najat M.
    El Ashiry, Eman A.
    Yagmoor, Mohammed A.
    Alzain, Soha M.
    PEDIATRIC DENTISTRY, 2015, 37 (07) : 535 - 540
  • [43] Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
    Bruemmendorf, Tim H.
    Cortes, Jorge E.
    de Souza, Carmino Antonio
    Guilhot, Francois
    Duvillie, Ladan
    Pavlov, Dmitri
    Gogat, Karin
    Countouriotis, Athena M.
    Gambacorti-Passerini, Carlo
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 69 - 81
  • [44] Efficacy of routine follow-up after first-line treatment for testicular cancer
    Spermon, JR
    Witjes, JA
    Kiemeney, LALM
    WORLD JOURNAL OF UROLOGY, 2004, 22 (04) : 235 - 243
  • [45] Efficacy of routine follow-up after first-line treatment for testicular cancer
    J. R. Spermon
    J. A. Witjes
    L. A. L. M. Kiemeney
    World Journal of Urology, 2004, 22 : 235 - 243
  • [46] Randomized clinical trial of the efficacy, tolerability, and long-term color stability of two bleaching techniques: 18-month follow-up
    Auschill, Thorsten M.
    Schneider-Del Savio, Thorsten
    Hellwig, Elmar
    Arweiler, Nicole B.
    QUINTESSENCE INTERNATIONAL, 2012, 43 (08): : 683 - 694
  • [47] Myopia control with soft multifocal contact lenses: 18-month follow-up
    Raffa, Lina H.
    Allinjawi, Kareem
    Sharanjeet-Kaur
    Akhir, Saadah M.
    Mutalib, Haliza A.
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2021, 35 (04) : 325 - 331
  • [48] Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up
    Marius K. Nickel
    Thomas H. Loew
    Francisco Pedrosa Gil
    Psychopharmacology, 2007, 191 : 1023 - 1026
  • [49] SPONTANEOUS CHANGES IN BRONCHIAL RESPONSIVENESS IN CHILDREN AND ADOLESCENTS - AN 18-MONTH FOLLOW-UP
    BACKER, V
    GROTH, S
    DIRKSEN, A
    PEDIATRIC PULMONOLOGY, 1991, 11 (01) : 22 - 28
  • [50] EXPRESSED EMOTION AND SCHIZOPHRENIA - THE ONTOGENY OF EE DURING AN 18-MONTH FOLLOW-UP
    STIRLING, J
    TANTAM, D
    THOMAS, P
    NEWBY, D
    MONTAGUE, L
    RING, N
    ROWE, S
    PSYCHOLOGICAL MEDICINE, 1993, 23 (03) : 771 - 778